X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (10375) 10375
life sciences & biomedicine (9953) 9953
humans (7296) 7296
male (7282) 7282
cardiovascular system & cardiology (6475) 6475
animals (5951) 5951
cardiac & cardiovascular systems (5888) 5888
female (4646) 4646
heart failure (3695) 3695
middle aged (3163) 3163
rats (2720) 2720
ventricular remodeling - drug effects (2589) 2589
aged (2460) 2460
echocardiography (2154) 2154
cardiology (2120) 2120
heart (2102) 2102
disease models, animal (1939) 1939
treatment outcome (1833) 1833
heart failure - physiopathology (1797) 1797
abridged index medicus (1642) 1642
myocardium - pathology (1607) 1607
cardiovascular (1541) 1541
ventricular remodeling (1524) 1524
ventricular function, left - drug effects (1508) 1508
time factors (1495) 1495
adult (1490) 1490
hypertension (1475) 1475
peripheral vascular disease (1471) 1471
myocardial infarction - physiopathology (1422) 1422
myocardial infarction (1372) 1372
risk factors (1359) 1359
medicine & public health (1329) 1329
mice (1292) 1292
myocardium - metabolism (1280) 1280
physiology (1255) 1255
analysis (1200) 1200
rats, sprague-dawley (1181) 1181
ventricular function, left (1170) 1170
care and treatment (1167) 1167
ventricular dysfunction, left - physiopathology (1162) 1162
pharmacology & pharmacy (1151) 1151
ventricular remodeling - physiology (1147) 1147
heart failure - drug therapy (1108) 1108
heart diseases (1106) 1106
heart attacks (1101) 1101
ventricle (1037) 1037
fibrosis (1027) 1027
myocardial infarction - drug therapy (1020) 1020
electrocardiography (1019) 1019
mortality (974) 974
rats, wistar (966) 966
research (962) 962
stroke volume (905) 905
blood pressure (888) 888
prognosis (877) 877
myocardial infarction - pathology (875) 875
cardiac patients (859) 859
heart attack (841) 841
heart ventricles - physiopathology (824) 824
prospective studies (824) 824
health aspects (821) 821
ventricular function, left - physiology (814) 814
blood pressure - drug effects (811) 811
cardiovascular disease (807) 807
follow-up studies (807) 807
cardiovascular diseases (798) 798
cardiomyopathy (790) 790
rodents (777) 777
hypertrophy (764) 764
hypertrophy, left ventricular - physiopathology (741) 741
hypertension - physiopathology (706) 706
mice, inbred c57bl (701) 701
heart failure - therapy (695) 695
drug therapy (684) 684
physiological aspects (684) 684
remodeling (684) 684
cardiovascular system (683) 683
myocytes, cardiac - drug effects (663) 663
cell biology (652) 652
pulmonary hypertension (650) 650
cardiology and cardiovascular medicine (645) 645
ventricular dysfunction, left - etiology (623) 623
angiotensin-converting enzyme inhibitors - therapeutic use (621) 621
myocytes, cardiac - metabolism (620) 620
myocardial infarction - complications (619) 619
heart ventricles - pathology (612) 612
studies (605) 605
heart failure - etiology (600) 600
medicine (600) 600
heart ventricles - drug effects (592) 592
medicine, research & experimental (581) 581
research & experimental medicine (581) 581
heart - drug effects (575) 575
apoptosis (572) 572
hemodynamics - drug effects (572) 572
myocardial infarction - metabolism (569) 569
hypertension - drug therapy (565) 565
left ventricular hypertrophy (562) 562
retrospective studies (560) 560
hemodynamics (552) 552
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13125) 13125
Chinese (97) 97
Japanese (91) 91
Russian (61) 61
Portuguese (60) 60
German (36) 36
French (20) 20
Spanish (17) 17
Italian (16) 16
Polish (5) 5
Ukrainian (5) 5
Dutch (3) 3
Czech (2) 2
Lithuanian (2) 2
Slovak (2) 2
Turkish (2) 2
Bosnian (1) 1
Hungarian (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American journal of cardiology, ISSN 0002-9149, 2013, Volume 111, Issue 10, pp. 1394 - 1400
Journal Article
American journal of physiology. Heart and circulatory physiology, ISSN 1522-1539, 02/2009, Volume 296, Issue 2, pp. H404 - H412
.... In the present study, we hypothesize that Ac-SDKP prevents Gal-3-induced cardiac inflammation, remodeling, and dysfunction, and these effects are mediated by the transforming growth factor (TGF)-β... 
N-acetyl-seryl-aspartyl-lysyl-proline | Inflammation | Cardiac dysfunction | Fibrosis | Cardiac & Cardiovascular Systems | Physiology | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Inflammation - chemically induced | Phosphorylation | Body Weight - drug effects | Myocardial Contraction - drug effects | Male | Smad3 Protein - metabolism | Heart Rate - drug effects | Inflammation - metabolism | Time Factors | Myocardium - metabolism | Echocardiography, Doppler | Anti-Inflammatory Agents - administration & dosage | Blood Pressure - drug effects | Disease Models, Animal | Macrophages - pathology | Oligopeptides - blood | Anti-Inflammatory Agents - pharmacology | Cardiac Output - drug effects | Ventricular Function, Left - drug effects | Cardiomegaly - physiopathology | Infusions, Parenteral | Rats | Stroke Volume - drug effects | Myocardium - pathology | Cardiotonic Agents - pharmacology | Mast Cells - drug effects | Rats, Sprague-Dawley | Anti-Inflammatory Agents - blood | Collagen - metabolism | Animals | Cardiomegaly - prevention & control | Cardiotonic Agents - administration & dosage | Signal Transduction - drug effects | Cardiotonic Agents - blood | Isoproterenol - pharmacology | Mast Cells - pathology | Cardiomegaly - chemically induced | Galectin 3 | Macrophages - drug effects | Hemodynamics - drug effects | Inflammation - prevention & control | Oligopeptides - administration & dosage | Oligopeptides - pharmacology | Transforming Growth Factor beta - metabolism | Ventricular Remodeling - drug effects | Cardiomegaly - metabolism | Inflammation - physiopathology | Index Medicus | cardiac dysfunction | fibrosis | inflammation
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2017, Volume 117, Issue 5, pp. 911 - 922
.... We aimed to determine the linkage of platelet activation to post-infarct left ventricular remodelling (LVR) process... 
Cellular Haemostasis and Platelets | Myocardial infarction | LV remodelling | Inflammation | Platelet reactivity | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Multivariate Analysis | Prospective Studies | Purinergic P2Y Receptor Antagonists - administration & dosage | Humans | Middle Aged | Receptors, Purinergic P2Y12 - drug effects | Male | Aspirin - administration & dosage | ST Elevation Myocardial Infarction - blood | ST Elevation Myocardial Infarction - therapy | Purinergic P2Y Receptor Antagonists - adverse effects | Percutaneous Coronary Intervention - instrumentation | C-Reactive Protein - metabolism | Receptors, Purinergic P2Y12 - blood | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Female | Blood Platelets - drug effects | Odds Ratio | Stents | Platelet Aggregation Inhibitors - adverse effects | Echocardiography | Ventricular Function, Left - drug effects | Inflammation Mediators - blood | Linear Models | Logistic Models | Treatment Outcome | Biomarkers - blood | Chi-Square Distribution | Ticlopidine - analogs & derivatives | ST Elevation Myocardial Infarction - physiopathology | Blood Platelets - metabolism | ST Elevation Myocardial Infarction - diagnostic imaging | Aged | Platelet Activation - drug effects | Percutaneous Coronary Intervention - adverse effects | Ventricular Remodeling - drug effects
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2013, Volume 182, Issue 3, pp. 701 - 713
We investigated the effect of resveratrol, a popular natural polyphenolic compound with antioxidant and proautophagic actions, on postinfarction heart failure... 
Pathology | Life Sciences & Biomedicine | Science & Technology | Sirtuin 1 - metabolism | AMP-Activated Protein Kinases - metabolism | Vacuoles - ultrastructure | Stilbenes - therapeutic use | TOR Serine-Threonine Kinases - metabolism | Apoptosis - drug effects | Heart Failure - enzymology | Heart Failure - physiopathology | Male | Stilbenes - pharmacology | Vacuoles - drug effects | Autophagy - drug effects | Adenosine Triphosphate - metabolism | Myocardial Infarction - pathology | Myocardial Infarction - physiopathology | Densitometry | Proto-Oncogene Proteins c-akt - metabolism | Superoxide Dismutase - metabolism | Myocardial Infarction - enzymology | Myocardium - ultrastructure | Animals, Newborn | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | AMP-Activated Protein Kinases - antagonists & inhibitors | Cells, Cultured | Myocardium - pathology | Heart Failure - pathology | Heart Failure - drug therapy | Myocytes, Cardiac - pathology | Animals | Myocardial Infarction - drug therapy | Myocytes, Cardiac - drug effects | Signal Transduction - drug effects | Vacuoles - metabolism | Heart Function Tests - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Myocytes, Cardiac - ultrastructure | Ventricular Remodeling - drug effects | Energy Metabolism - drug effects | Index Medicus | Abridged Index Medicus
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 03/2008, Volume 117, Issue 11, pp. 1388 - 1396
Background-Adverse cardiac remodeling and progression of heart failure after myocardial infarction are associated with excessive and continuous damage to the extracellular matrix... 
Heart failure | Myocardial infarction | Tissue | Remodeling | Tissue engineering | Collagen | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Viscosity | Alginates - therapeutic use | Biocompatible Materials - chemistry | Hexuronic Acids - administration & dosage | Male | Myocardial Infarction - diagnostic imaging | Injections, Intralesional | Hydrogels - administration & dosage | Myocardial Infarction - pathology | Ultrasonography | Glucuronic Acid - administration & dosage | Drug Evaluation, Preclinical | Glucuronic Acid - chemistry | Alginates - pharmacology | Cicatrix - diagnostic imaging | Myocardial Infarction - surgery | Drug Administration Schedule | Hypertrophy, Left Ventricular - etiology | Hypertrophy, Left Ventricular - prevention & control | Rats | Ventricular Dysfunction, Left - etiology | Glucuronic Acid - therapeutic use | Materials Testing | Biocompatible Materials - pharmacology | Hexuronic Acids - chemistry | Random Allocation | Rats, Sprague-Dawley | Ventricular Dysfunction, Left - diagnostic imaging | Ventricular Dysfunction, Left - prevention & control | Myocytes, Cardiac - transplantation | Alginates - administration & dosage | Glucuronic Acid - pharmacology | Animals | Myocardial Infarction - drug therapy | Alginates - chemistry | Biocompatible Materials - administration & dosage | Biocompatible Materials - therapeutic use | Cicatrix - pathology | Hydrogels - pharmacology | Hydrogels - therapeutic use | Ventricular Remodeling - drug effects | Hexuronic Acids - pharmacology | Hexuronic Acids - therapeutic use | Hypertrophy, Left Ventricular - diagnostic imaging | Prevention | Usage | Animal models in research | Patient outcomes | Development and progression | Drug therapy | Heart attack | Index Medicus | Abridged Index Medicus
Journal Article
Circulation research, ISSN 0009-7330, 03/2012, Volume 110, Issue 5, pp. 739 - 748
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 1524-4563, 07/2014, Volume 64, Issue 1, pp. 157 - 164
Journal Article
PloS one, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, pp. e0124606 - e0124606
... I), we used this model to analyze the effects of an extracellular CyPA inhibition. As extracellular CyPA-inhibitor... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Tumor Necrosis Factor-alpha - metabolism | Autoimmune Diseases - physiopathology | Inflammation - pathology | Humans | Myocarditis - drug therapy | Cyclosporins - pharmacology | Inflammation - complications | Matrix Metalloproteinase 9 - metabolism | Cyclosporins - therapeutic use | T-Lymphocytes - drug effects | Monocytes - pathology | Autoimmune Diseases - pathology | Interleukin-6 - metabolism | Autoimmune Diseases - drug therapy | Disease Models, Animal | Cyclophilin A - metabolism | Myocarditis - complications | Autoimmune Diseases - complications | Myocardium - pathology | Cell Adhesion - drug effects | Monocytes - drug effects | Cell Movement - drug effects | Cyclophilin A - antagonists & inhibitors | Animals | Troponin I | Fibrosis | Extracellular Space - chemistry | Macrophages - drug effects | Mice | Myocarditis - pathology | Myocarditis - physiopathology | Ventricular Remodeling - drug effects | Myocarditis | Models | Inflammation | Prognosis | T cells | Leukocyte migration | Cardiomyopathy | Neuropathology | Lymphocytes T | Macrophages | Interleukin 6 | Reduction | Ischemia | Calcium-binding protein | Inhibition | Heart diseases | Injury analysis | Heart failure | Pathogens | Peptidylprolyl isomerase | Immunization | Internal medicine | Cytokines | Pharmacology | Tumor necrosis factor-α | Gelatinase B | Medicine | Studies | Pathology | Monocytes | Troponin | Injury prevention | Inhibitors | Cell death | Index Medicus
Journal Article
Journal Article